The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Global Nucleic Acid Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Delivery System market research.
Key companies engaged in the Nucleic Acid Delivery System industry include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nucleic Acid Delivery System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Delivery System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nucleic Acid Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Creative Biogene
- Evonik Health Care
- Factor Bioscience
- Polyplus
- AccuRna
Segment by Vector
- Viral Vectors
- Lipid-based Carriers
- Protein-based Carriers
Segment by Application
- Drug Development
- Gene Therapy
- Biopharmaceuticals
- Scientific Research
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Nucleic Acid Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Vector and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Vector Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Vector
1.2.1 Global Nucleic Acid Delivery System Market Size Growth Rate by Vector: 2018 VS 2022 VS 2029
1.2.2 Viral Vectors
1.2.3 Lipid-based Carriers
1.2.4 Protein-based Carriers
1.3 Market by Application
1.3.1 Global Nucleic Acid Delivery System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Development
1.3.3 Gene Therapy
1.3.4 Biopharmaceuticals
1.3.5 Scientific Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Delivery System Market Perspective (2018-2029)
2.2 Nucleic Acid Delivery System Growth Trends by Region
2.2.1 Global Nucleic Acid Delivery System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nucleic Acid Delivery System Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Delivery System Forecasted Market Size by Region (2024-2029)
2.3 Nucleic Acid Delivery System Market Dynamics
2.3.1 Nucleic Acid Delivery System Industry Trends
2.3.2 Nucleic Acid Delivery System Market Drivers
2.3.3 Nucleic Acid Delivery System Market Challenges
2.3.4 Nucleic Acid Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Delivery System Players by Revenue
3.1.1 Global Top Nucleic Acid Delivery System Players by Revenue (2018-2023)
3.1.2 Global Nucleic Acid Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Delivery System Revenue
3.4 Global Nucleic Acid Delivery System Market Concentration Ratio
3.4.1 Global Nucleic Acid Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Delivery System Revenue in 2022
3.5 Nucleic Acid Delivery System Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Delivery System Product Solution and Service
3.7 Date of Enter into Nucleic Acid Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Delivery System Breakdown Data by Vector
4.1 Global Nucleic Acid Delivery System Historic Market Size by Vector (2018-2023)
4.2 Global Nucleic Acid Delivery System Forecasted Market Size by Vector (2024-2029)
5 Nucleic Acid Delivery System Breakdown Data by Application
5.1 Global Nucleic Acid Delivery System Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Delivery System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nucleic Acid Delivery System Market Size (2018-2029)
6.2 North America Nucleic Acid Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nucleic Acid Delivery System Market Size by Country (2018-2023)
6.4 North America Nucleic Acid Delivery System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Delivery System Market Size (2018-2029)
7.2 Europe Nucleic Acid Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nucleic Acid Delivery System Market Size by Country (2018-2023)
7.4 Europe Nucleic Acid Delivery System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Delivery System Market Size (2018-2029)
8.2 Asia-Pacific Nucleic Acid Delivery System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nucleic Acid Delivery System Market Size by Region (2018-2023)
8.4 Asia-Pacific Nucleic Acid Delivery System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Delivery System Market Size (2018-2029)
9.2 Latin America Nucleic Acid Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nucleic Acid Delivery System Market Size by Country (2018-2023)
9.4 Latin America Nucleic Acid Delivery System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Delivery System Market Size (2018-2029)
10.2 Middle East & Africa Nucleic Acid Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nucleic Acid Delivery System Market Size by Country (2018-2023)
10.4 Middle East & Africa Nucleic Acid Delivery System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biogene
11.1.1 Creative Biogene Company Detail
11.1.2 Creative Biogene Business Overview
11.1.3 Creative Biogene Nucleic Acid Delivery System Introduction
11.1.4 Creative Biogene Revenue in Nucleic Acid Delivery System Business (2018-2023)
11.1.5 Creative Biogene Recent Development
11.2 Evonik Health Care
11.2.1 Evonik Health Care Company Detail
11.2.2 Evonik Health Care Business Overview
11.2.3 Evonik Health Care Nucleic Acid Delivery System Introduction
11.2.4 Evonik Health Care Revenue in Nucleic Acid Delivery System Business (2018-2023)
11.2.5 Evonik Health Care Recent Development
11.3 Factor Bioscience
11.3.1 Factor Bioscience Company Detail
11.3.2 Factor Bioscience Business Overview
11.3.3 Factor Bioscience Nucleic Acid Delivery System Introduction
11.3.4 Factor Bioscience Revenue in Nucleic Acid Delivery System Business (2018-2023)
11.3.5 Factor Bioscience Recent Development
11.4 Polyplus
11.4.1 Polyplus Company Detail
11.4.2 Polyplus Business Overview
11.4.3 Polyplus Nucleic Acid Delivery System Introduction
11.4.4 Polyplus Revenue in Nucleic Acid Delivery System Business (2018-2023)
11.4.5 Polyplus Recent Development
11.5 AccuRna
11.5.1 AccuRna Company Detail
11.5.2 AccuRna Business Overview
11.5.3 AccuRna Nucleic Acid Delivery System Introduction
11.5.4 AccuRna Revenue in Nucleic Acid Delivery System Business (2018-2023)
11.5.5 AccuRna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
